Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial of Convalescent Plasma Administration as Adjunct Therapy for COVID-19 (Uji Klinik Pemberian Plasma Konvalesen Sebagai Terapi Tambahan COVID-19)

NCT04873414 is registered in ClinicalTrials.gov with National Institute of Health Research and Development, Ministry of Health Republic of Indonesia as lead sponsor.

NCT NCT04873414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04873414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial of Convalescent Plasma Administration as Adjunct Therapy for COVID-19 (Uji Klinik Pemberian Plasma Konvalesen Sebagai Terapi Tambahan COVID-19)
Lead sponsor
National Institute of Health Research and Development, Ministry of Health Republic of Indonesia
Phase
Phase 2/3
Overall status
Unknown status
Start date
December 1, 2020
Completion date
December 31, 2021
Enrollment
364 (estimated)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19